TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31465307

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) performed twice daily for 4 weeks starting 3 days after surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: IMT placebo group (IMT-PG)
Number of subjects: 0
Study: 29504328

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8mg intravenously preoperatively and second dose 4 hours postoperatively
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60
Study: 26827617

Group type: EXPERIMENTAL
Intervention: Feedback-incentive (monthly letter with social norm feedback plus small financial incentive for increasing green purchases)
Number of subjects: 2672

Group type: EXPERIMENTAL
Intervention: Feedback-only (monthly letter with social norm feedback about healthy food purchases)
Number of subjects: 2672

Group type: COMPARATOR
Intervention: Control (no contact)
Number of subjects: 2672

Group type: EXPERIMENTAL
Intervention: Feedback-incentive
Number of subjects: 2672
Study: 25113814

Group type: EXPERIMENTAL
Intervention: InsuPad
Number of subjects: 20
Study: 22693239

Group type: EXPERIMENTAL
Intervention: CHO‐PRO solution (1.2 g CHO/kg body mass and 0.4 g PRO/kg body mass)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: CHO‐PRO solution
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo solution (CON)
Number of subjects: 11
Study: 19897389

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 18375410

Group type: EXPERIMENTAL
Intervention: Diane(35) Diario (35 mg ethinyl-estradiol plus 2 mg cyproterone acetate)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Metformin (850 mg twice daily)
Number of subjects: 40
Study: 11672911

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: DTP vaccination
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: Positive tuberculin reaction
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: BCG vaccination before last DTP vaccine
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: Sick children
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: Rainy season
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: Antimalarials within last week
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: BCG vaccination before 1 month of age
Number of subjects: 884
Study: 9129845

Group type: EXPERIMENTAL
Intervention: Clinical data (history of myocardial infarction, pathological Q‐wave in resting ECG, systolic blood pressure at maximal exercise, degree of mitral regurgitation)
Number of subjects: 663

Group type: COMPARATOR
Intervention: Exercise test results
Number of subjects: 663
Study: 7961349

Group type: EXPERIMENTAL
Intervention: Therapy received by 65% of abused children for an average of 9 months.
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Self-esteem, depression, and behavior scores of abused children.
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Family dysfunction assessment.
Number of subjects: 84
Study: 3298694

Group type: EXPERIMENTAL
Intervention: Bacillus Calmette-Guerin therapy with quarterly maintenance instillations
Number of subjects: 42

Group type: COMPARATOR
Intervention: Bacillus Calmette-Guerin therapy without maintenance instillations
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Maintenance bacillus Calmette-Guerin therapy
Number of subjects: 42
Study: 29603537

Group type: EXPERIMENTAL
Intervention: Waist-to-height ratio (WHtR)
Number of subjects: 11125

Group type: COMPARATOR
Intervention: Body mass index (BMI)
Number of subjects: 11125

Group type: COMPARATOR
Intervention: Waist circumference
Number of subjects: 11125

Group type: COMPARATOR
Intervention: Waist hip ratio (WHR)
Number of subjects: 11125
Study: 27840413

Group type: EXPERIMENTAL
Intervention: Very-Low-Calorie Diet (VLCD; 500 kcal/day) for 5 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Low-Calorie Diet (LCD; 1250 kcal/day) for 12 weeks
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Comparison of VLCD and LCD during the dietary intervention (DI) period
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: VLCD during the WL period and DI period
Number of subjects: 53
Study: 26329352

Group type: EXPERIMENTAL
Intervention: Preventive nebulization of acetylcysteine and salbutamol
Number of subjects: 950

Group type: COMPARATOR
Intervention: Nebulization of acetylcysteine and/or salbutamol on indication
Number of subjects: 950
Study: 23132658

Group type: EXPERIMENTAL
Intervention: Breath holding (BH) duration
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Self-reported intolerance of smoking abstinence
Number of subjects: 96
Study: 21167334

Group type: EXPERIMENTAL
Intervention: Platelet function monitoring with dose adjustment in suboptimal responders
Number of subjects: 2466

Group type: EXPERIMENTAL
Intervention: Continuation of dual antiplatelet therapy beyond 1 year
Number of subjects: 2466

Group type: COMPARATOR
Intervention: Standard of care without monitoring and without dose adjustment
Number of subjects: 2466
Study: 18391346

Group type: EXPERIMENTAL
Intervention: Haptic training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual training
Number of subjects: 0
Study: 17184230

Group type: EXPERIMENTAL
Intervention: Fluoridated dentifrice preceded by calcium lactate rinse
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Placebo dentifrice preceded by calcium lactate rinse
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fluoridated dentifrice preceded by deionized water prerinse
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Placebo dentifrice preceded by deionized water prerinse
Number of subjects: 16

Group type: COMPARATOR
Intervention: Calcium lactate prerinse
Number of subjects: 16
Study: 14870949

Group type: EXPERIMENTAL
Intervention: MDMA 75 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Alcohol 0.5 g/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 10929961

Group type: EXPERIMENTAL
Intervention: 5 mm diagnostic sheath (Group 1)
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: 5 mm sheath with paracervical block (Group 2)
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: 3.5 mm sheath (Group 3)
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Paracervical block (Group 2)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Comparison of pain scores across groups
Number of subjects: 362
Study: 9039228

Group type: EXPERIMENTAL
Intervention: Radiotherapy alone (extended fields, 4500 cGy)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Radiotherapy plus adjuvant chemotherapy (cyclophosphamide, vincristine and prednisone)
Number of subjects: 39
Study: 1357681

Group type: EXPERIMENTAL
Intervention: CGP 361 A (beta-blocking drug)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flupenthixol (low-dose neuroleptic)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29990442

Group type: COMPARATOR
Intervention: Dietary modification (group D)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Exercise training and dietary modification (group DE)
Number of subjects: 48
Study: 29934046

Group type: EXPERIMENTAL
Intervention: DHA supplementation (0.5, 1, and 2 g daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: DHA supplementation
Number of subjects: 60
Study: 27239991

Group type: EXPERIMENTAL
Intervention: Cytoflavin (2 tabs. 2 times a day for 25 days) + cognitive therapy
Number of subjects: 103
Study: 25151398

Group type: EXPERIMENTAL
Intervention: Benson's relaxation response technique (2-week intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study: 21667181

Group type: EXPERIMENTAL
Intervention: Single-bundle ACL reconstruction
Number of subjects: 60

Group type: COMPARATOR
Intervention: Double-bundle ACL reconstruction
Number of subjects: 60
Study: 19116781

Group type: EXPERIMENTAL
Intervention: FOYC (Focus on Youth in the Caribbean)
Number of subjects: 1360
Study: 18403130

Group type: EXPERIMENTAL
Intervention: Socially evaluated cold-pressor test (SECPT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard cold-pressor test (CPT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Social evaluation during hand immersion in warm water
Number of subjects: 70
Study: 15721098

Group type: EXPERIMENTAL
Intervention: Higher initial resting ventricular rate (IRVR)
Number of subjects: 4059

Group type: COMPARATOR
Intervention: Adequate rate control
Number of subjects: 4059
Study: 12860497

Group type: EXPERIMENTAL
Intervention: Galantamine 24 mg/d
Number of subjects: 459

Group type: COMPARATOR
Intervention: Placebo followed by Galantamine 24 mg/d
Number of subjects: 459
Study: 10100083

Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 90

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 90
Study: 8655703

Group type: EXPERIMENTAL
Intervention: Single-tube nested PCR
Number of subjects: 2033
Study: 2004540

Group type: EXPERIMENTAL
Intervention: Liquid formulation (1.67 mg/ml)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 200 mg tablet (2 x 200 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 400 mg tablet
Number of subjects: 24
Study: 6439360

Group type: EXPERIMENTAL
Intervention: Theophylline (200, 400, 600, and 800 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31369593

Group type: EXPERIMENTAL
Intervention: oXiris filter
Number of subjects: 16

Group type: COMPARATOR
Intervention: standard filter
Number of subjects: 16
Study: 29454514

Group type: EXPERIMENTAL
Intervention: Intermittent linsitinib (600mg once daily on Days 1-3 per week) with paclitaxel (80mg/m2 on Days 1, 8, and 15)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Continuous linsitinib (150mg twice daily) with paclitaxel (80mg/m2 on Days 1, 8, and 15)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Paclitaxel alone
Number of subjects: 152
Study: 26857248

Group type: EXPERIMENTAL
Intervention: Balneotherapy (BT) in addition to physical therapy (PT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Physical therapy (PT) alone
Number of subjects: 60
Study: 24172160

Group type: EXPERIMENTAL
Intervention: Levomilnacipran ER 75 or 100 mg/day
Number of subjects: 75
Study: 22038336

Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL)
Number of subjects: 13

Group type: COMPARATOR
Intervention: CNI
Number of subjects: 13
Study: 19270108

Group type: EXPERIMENTAL
Intervention: Adjuvant! decision aid
Number of subjects: 395

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 395
Study: 17311014

Group type: EXPERIMENTAL
Intervention: Pharmacy technician‐led medication review and counselling clinic
Number of subjects: 0
Study: 15637232

Group type: EXPERIMENTAL
Intervention: Magnesium intake
Number of subjects: 0
Study: 11593218

Group type: EXPERIMENTAL
Intervention: 3-minute adenosine infusion at 140 microg/kg per minute
Number of subjects: 599

Group type: COMPARATOR
Intervention: 6-minute adenosine infusion at 140 microg/kg per minute
Number of subjects: 599
Study: 9638504

Group type: EXPERIMENTAL
Intervention: Lysine clonixinate (125 mg tablet every 4 h for 2 days)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Paracetamol/codeine (500 mg + 30 mg every 4 h for 2 days)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Paracetamol/codeine (500 mg + 30 mg)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Lysine clonixinate (125 mg)
Number of subjects: 151
Study: 8206470

Group type: EXPERIMENTAL
Intervention: 2% clindamycin vaginal cream
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 2492462

Group type: EXPERIMENTAL
Intervention: Oximetrix Opticath (flow-directed PA catheter utilizing reflective fiberoptic oximetry for continuous Sv‐O2 monitoring)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Edwards quadruple‐lumen flow‐directed PA catheter
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Mixed venous oximetry
Number of subjects: 99
Study: 1138844

Group type: EXPERIMENTAL
Intervention: Intravenous Diamox with variable doses of Pilocarpine
Number of subjects: 0
Study: 31627057

Group type: EXPERIMENTAL
Intervention: Less tight control (target diastolic BP 100 mmHg)
Number of subjects: 987

Group type: COMPARATOR
Intervention: Tight control (target diastolic BP 85 mmHg)
Number of subjects: 987

Group type: EXPERIMENTAL
Intervention: Less tight control
Number of subjects: 987

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 987
Study: 27299461

Group type: EXPERIMENTAL
Intervention: Nebulization of Shenmai Injection (0.6 mL/kg in 10 mL normal saline)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Intravenous drip of Shenmai Injection (0.6 mL/kg dissolved in 250 mL of 10% glucose)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Normal saline (NS) control group (equal volume given intravenously)
Number of subjects: 38
Study: 25424589

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dexmedetomidine
Number of subjects: 60
Study: 23141748

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21192206

Group type: EXPERIMENTAL
Intervention: Appreciative Inquiry (AI) quality improvement strategy
Number of subjects: 30
Study: 18652328

Group type: EXPERIMENTAL
Intervention: Warming-removing obstruction needling method
Number of subjects: 62

Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 62
Study: 17160910

Group type: EXPERIMENTAL
Intervention: DPP IV inhibitors (gliptins)
Number of subjects: 0
Study: 12532097

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluticasone propionate 250 microg administered twice daily
Number of subjects: 0
Study: 11233712

Group type: EXPERIMENTAL
Intervention: Combination of azelastine and beclomethasone administered together (morning and evening, with a 5-minute interval)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Combination of azelastine and beclomethasone administered separately (azelastine in the morning and evening, beclomethasone later during the morning and in the afternoon)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Combination of azelastine and beclomethasone
Number of subjects: 219
Study: 8895908

Group type: EXPERIMENTAL
Intervention: 89Sr (148 MBq) followed by carboplatin (100 mg m‐2 at 7 and 21 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 89Sr alone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 89Sr and carboplatin
Number of subjects: 30
Study: 1900379

Group type: EXPERIMENTAL
Intervention: deferoxamine (chelation therapy)
Number of subjects: 31

Group type: COMPARATOR
Intervention: no chelation therapy (control group)
Number of subjects: 31
Study: 6198367

Group type: EXPERIMENTAL
Intervention: mezlocillin and metronidazole
Number of subjects: 36

Group type: COMPARATOR
Intervention: cefuroxime and metronidazole
Number of subjects: 36
Study: 31764095

Group type: EXPERIMENTAL
Intervention: Daily oral tenofovir disoproxil fumarate (TDF) for preexposure prophylaxis (PrEP)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 29357843

Group type: EXPERIMENTAL
Intervention: Women for Women International (WfWI) intervention, a year-long combined economic and social empowerment program.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified in the abstract.
Number of subjects: 0
Study: 28243779

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 13
Study: 24747867

Group type: EXPERIMENTAL
Intervention: Combination therapy with peginterferon alfa-2a 135 μg/week plus ribavirin 200 mg/day (n=86)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Peginterferon alfa-2a 135 μg/week (n=86)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 172

Group type: COMPARATOR
Intervention: Monotherapy
Number of subjects: 172
Study: 24473718

Group type: EXPERIMENTAL
Intervention: Low-fluoride dentifrices (0-275, 275-550, 550-1,100 µg F/g)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-fluoride dentifrices (1,100 µg F/g)
Number of subjects: 0
Study: 21632123

Group type: EXPERIMENTAL
Intervention: Mouth breathing during childhood (SG)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 24
Study: 18280833

Group type: EXPERIMENTAL
Intervention: Integrated Care Pathway (ICP)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 298
Study: 16199429

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg twice daily)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Weight loss through lifestyle changes
Number of subjects: 143
Study: 12955343

Group type: EXPERIMENTAL
Intervention: NEAT device
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reliance Insert
Number of subjects: 24
Study: 10934930

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with propofol and midazolam coinduction
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (first group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (third group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (fourth group)
Number of subjects: 80
Study: 9058494

Group type: EXPERIMENTAL
Intervention: Tranexamic acid administered intravenously at the end of the operation, repeated three hours later.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo administered to control group.
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (I)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 24
Study: 8477179

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 3718586

Group type: EXPERIMENTAL
Intervention: Brotizolam (0.25 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flurazepam (30 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31633576

Group type: EXPERIMENTAL
Intervention: Ketamine (1 mg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline (0.1 ml/kg)
Number of subjects: 20
Study: 30526533

Group type: EXPERIMENTAL
Intervention: Fractional Polynomials (FP) transformations
Number of subjects: 4479

Group type: EXPERIMENTAL
Intervention: Restricted Cubic Splines (RCS) transformations
Number of subjects: 4479

Group type: COMPARATOR
Intervention: Dichotomized predictors
Number of subjects: 4479

Group type: EXPERIMENTAL
Intervention: Categorized predictors into three or four groups
Number of subjects: 4479

Group type: EXPERIMENTAL
Intervention: Validation set models based on FP and RCS transformations
Number of subjects: 4479
Study: 27684878

Group type: EXPERIMENTAL
Intervention: Remifentanil (effective effect-site concentration for 50% [EC50])
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Remifentanil (effective effect-site concentration for 95% [EC95])
Number of subjects: 48
Study: 24743662

Group type: EXPERIMENTAL
Intervention: Healthy Love intervention, a 3-4 hour interactive educational workshop
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Culturally tailored, interactive group intervention efforts
Number of subjects: 0
Study: 23298894

Group type: EXPERIMENTAL
Intervention: Pulsatile GnRH therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Combined gonadotropins (rFSH+rLH)
Number of subjects: 30
Study: 21934521

Group type: EXPERIMENTAL
Intervention: Lipo‐PGE1 (20 μg/day intravenously for 5 days)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard medical therapy (control group)
Number of subjects: 79
Study: 18600212

Group type: EXPERIMENTAL
Intervention: Systolic ABP
Number of subjects: 1167

Group type: COMPARATOR
Intervention: Systolic CBP
Number of subjects: 1167

Group type: COMPARATOR
Intervention: Systolic UBP
Number of subjects: 1167
Study: 16941968

Group type: EXPERIMENTAL
Intervention: Comprehensive program of acupuncture, moxibustion and massage
Number of subjects: 660

Group type: COMPARATOR
Intervention: Comprehensive program of physical therapy
Number of subjects: 660
Study: 14570664

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine sulfate (ITMS) 0.1 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine sulfate (ITMS) 0.2 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine sulfate (ITMS) 0.3 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intrathecal morphine sulfate (ITMS) 0.0 mg (control)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine sulfate (ITMS) (0.1, 0.2, 0.3 mg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine sulfate (ITMS) (0.2 mg)
Number of subjects: 80
Study: 10761163

Group type: EXPERIMENTAL
Intervention: Acetaminophen controlled-release (CR) sprinkles on applesauce
Number of subjects: 112

Group type: COMPARATOR
Intervention: Acetaminophen immediate-release (IR) elixir
Number of subjects: 112
Study: 8881732

Group type: EXPERIMENTAL
Intervention: Self‐expanding metal stents
Number of subjects: 474

Group type: COMPARATOR
Intervention: Laser treatment
Number of subjects: 474

Group type: COMPARATOR
Intervention: Chemotherapy (epirubicin, cisplatin, and 5‐fluorouracil)
Number of subjects: 474
Study: 1553892

Group type: EXPERIMENTAL
Intervention: Bepridil hydrochloride (HCl) at a mean maintenance dosage of 324 mg/day
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Propranolol HCl
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Bepridil combined with propranolol
Number of subjects: 75

Group type: COMPARATOR
Intervention: Propranolol plus placebo
Number of subjects: 75
Study: 3296615

Group type: EXPERIMENTAL
Intervention: DDS 100 mg 7/7 for 3 years
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: RMP 900 mg 1/7 for 8 doses
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: RMP 900 mg 7/7 for 12 doses
Number of subjects: 75
Study: 29551889

Group type: EXPERIMENTAL
Intervention: β‐asarone 10 mg/d, tenuigenin 10 mg/d, and memantine 5‐20 mg/d
Number of subjects: 152

Group type: COMPARATOR
Intervention: memantine 5‐20 mg/d
Number of subjects: 152
Study: 27973594

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moderate Continuous Training (MCT)
Number of subjects: 0